Volitionrx (VNRX) Total Current Liabilities (2019 - 2025)
Volitionrx (VNRX) has disclosed Total Current Liabilities for 9 consecutive years, with $11.4 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Total Current Liabilities fell 62.28% year-over-year to $11.4 million, compared with a TTM value of $11.4 million through Sep 2025, down 62.28%, and an annual FY2024 reading of $7.8 million, down 12.89% over the prior year.
- Total Current Liabilities was $11.4 million for Q3 2025 at Volitionrx, up from $9.2 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $31.5 million in Q1 2024 and bottomed at $5.4 million in Q2 2021.
- Average Total Current Liabilities over 5 years is $15.5 million, with a median of $17.1 million recorded in 2022.
- The sharpest move saw Total Current Liabilities surged 221.42% in 2022, then tumbled 73.73% in 2025.
- Year by year, Total Current Liabilities stood at $6.5 million in 2021, then skyrocketed by 166.83% to $17.4 million in 2022, then plummeted by 48.56% to $8.9 million in 2023, then dropped by 12.89% to $7.8 million in 2024, then skyrocketed by 46.61% to $11.4 million in 2025.
- Business Quant data shows Total Current Liabilities for VNRX at $11.4 million in Q3 2025, $9.2 million in Q2 2025, and $8.3 million in Q1 2025.